Indirect Tax Accountant at Bristol-Myers Squibb

Chester, England, United Kingdom

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Demonstrable experience of VAT compliance in at least one jurisdiction in a multi-national tax environment or equivalent
  • Experience with SAP or Oracle (advantageous)
  • Excellent Excel skills
  • Experience with Indirect Tax return preparation technology
  • Ability to successfully manage competing priorities
  • Ability to work with a range of technically and culturally diverse people
  • Ability to effectively communicate to a diverse audience, at multiple levels within the company
  • Autonomous working
  • Ability to establish formal relationships with internal customers
  • Demonstrates a team orientated approach
  • Ability to assess and resolve problems
  • Excellent analytical skills

Responsibilities

  • Preparation of monthly, bi-monthly, quarterly or annual VAT returns and other indirect tax returns (sales listings, domestic listings, purchase listings, Intrastat, SAF-T)
  • Review of monthly, bi-monthly, quarterly, or annual VAT returns and other indirect tax returns (sales listings, domestic listings, purchase listings, Intrastat, SAF-T)
  • Preparing and requesting necessary VAT submission approvals from internal stakeholders and following up on VAT payment requests and archiving documentation after submissions are completed
  • Preparation of VAT General Ledger reconciliation and follow up on issues and open items
  • Reconciliation of GL sales to reported VAT sales and follow up on issues and open items
  • Manage and assist with VAT compliance queries from the business
  • Support preparing VAT requirements documents and other documents
  • Support Tax Technology team to test and implement requirements
  • Continuous monitor of VAT legislation to identify relevant changes
  • Assistance in maintenance of VAT codes tables and VAT codes in accounting system
  • Assistance with VAT audits and liaison with tax authorities
  • Support strategy of standardisation and automation, continuous improvement and risk management

Skills

VAT compliance
VAT reporting
Tax legislation
Stakeholder management
International tax
European VAT

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI